Funding for this research was provided by:
National Institute on Aging (R01AG072758, R01AG054214, R01AG074541)
Tau Consortium
JPB Foundation
Cure Alzheimer's Fund
BrightFocus Foundation (A20201312F)
Article History
Received: 28 July 2023
Accepted: 25 October 2023
First Online: 8 November 2023
Declarations
:
: L.G. is founder and consultant of Aeton Therapeutics, Inc. S.C.S. is an equity holder and a consultant of Aeton Therapeutics, Inc.